Jiangsu (SH:688426) Zheng Quan Zhi Xing·2025-09-03 16:08Core Points - The company is holding its first extraordinary general meeting of shareholders in 2025 to discuss key proposals [1][4] - The meeting will address the completion of certain fundraising investment projects and the allocation of surplus funds to enhance liquidity [4][5] - The company plans to cancel its supervisory board and amend its articles of association, transferring supervisory responsibilities to the audit committee [6][7] Group 1: Meeting Procedures - Shareholders and their representatives must sign in 30 minutes before the meeting and present necessary identification documents [2] - Only authorized personnel, including shareholders, directors, and invited guests, are allowed to attend the meeting [3] - The meeting will be conducted with strict order, and any disruptive behavior will be addressed by staff [3][4] Group 2: Proposals - Proposal 1: The company intends to allocate surplus funds of 104.7854 million yuan from the "Medical Equipment and Biological Testing Reagent Industrialization Project" to enhance liquidity, having already invested 390.2415 million yuan out of the planned 486.6919 million yuan [5] - Proposal 2: The company proposes to abolish the supervisory board and allow the audit committee to assume its responsibilities, with necessary amendments to the articles of association [6][7] - Proposal 3: The company aims to revise and establish certain internal governance systems to align with the latest regulations and improve operational standards [7]